On the mid‑tier squeeze – too big to exit, too small to absorb the shock

Across the world, it is mid‑tier insurers that face the harshest combination of capital pressure, regulatory scrutiny and limited strategic options in the increasingly competitive insurance market.

In the UK specifically, the squeeze is primarily shaped by cost shocks and tighter funding conditions in a smaller market, as well as the impacts of energy, wage and interest rate turbulence.

Bank-led financing and a cautious investment environment present significant constraints to growth. So, in the UK, mid-tier insurers face limited domestic scale and fewer exit paths than those operating in the US.

This leaves many firms caught between mounting capital requirements and heightened regulatory scrutiny. Exiting the market could lead to significant disruption and yet many mid-tier companies are too small to weather the financial and operational shocks that are reshaping the sector.

Pivoting quickly

Mid-tier companies are often too large to pivot quickly, yet too small to match the platform-level efficiency of the globe’s largest competitors.

And while the impact can, in some cases, be similar, the US drivers of the mid-tier squeeze are about the economics of scale, geographical presence and capital market intensity.

For example, dominant national players in the US with a wider geographical spread can often outspend mid-sized firms on technology, marketing and labour.

Nevertheless, fragmented regulation and high fixed costs make doing nothing expensive – and potentially very risky.

Patrick Abbe, executive managing director at Aon, doesn’t fully agree with this argument however.

He explained: “In the US the exposure for mid-tier companies is not across the board. There are a number of mid-tier companies that are as well positioned for the future as their larger competitors. The ones that are in a less strong position are often narrower in their geographic scope.

“Companies with a broader footprint have tended to perform better over time as it helps to insulate them from climate volatility impacting key concentrations. In many cases, they also have more actuarial resources, for example, and more sophisticated products – deductible options, coverage options and a holding company structure that allows them to have more rate flexibility and to shift risk across several operating companies.

Abbe added that the companies most exposed in the current soft market lack the necessary systems, data, actuarial talent and responsive management teams to make decisive decisions quickly.

The mid-sized companies that have these in place have performed well despite lacking in scale. It is those that don’t which are now having to try to catch up – and they are feeling the squeeze the most.

Personal lines challenges

Saad Pervaiz, an associate director at Fitch Ratings, said the UK personal lines insurance market remains challenging for those without the requisite scale.

He told Insurance Times: “Pricing is still under pressure as competition remains strong, while claims inflation is elevated and volatile, particularly in motor, where repair and labour costs, as well as supply chain pressures, continue to weigh on profitability.”

Consolidation activity remains elevated too, he added, and insurers in the UK are looking for scale advantages, stronger efficiency and broader earnings diversification.

For example, he pointed out that “Aviva’s acquisition of DLG is a recent example of this, reflecting the strategic value of scale in personal lines through cost synergies, capital benefits and greater market reach.”

Companies are using targeted acquisitions to diversify their earnings and to strengthen their capabilities, according to Pervaiz.

“Admiral’s acquisition of More Than’s pet and home insurance business broadens its product mix, while its acquisition of Flock expands its presence in commercial fleet and adds technology-led capability,” he explained.

Scale is imperative

Dominic Roope, managing director at consultancy Alvarez and Marsal London’s practice, explained that the scale imperative for insurers exists particularly in personal lines. Without scale, he noted, the cost of operation rises as primary pricing power falls.

Roope’s analysis is that implicit consolidation, even without regulatory mandates, means the technology debt and misaligned reinsurance cycles are forcing a cycle of M&A as the only path to survival.

He also argued that specialisation is only successful if a given firm is a dominant player in a specific, complex line. Ergo, being a medium-sized generalist is no longer a viable strategy.

Then there is the equation of compressing bargaining power versus distribution. “Massive private equity-backed brokers and MGAs are consolidating, hence eroding margins of mid-tier carriers,” he claimed.

This is in addition to the supervisory requirements of regulators for capital add-ons, ORSA scrutiny, recovery and resolution planning under IRRD, operational resilience testing and conduct remediation.

“The marginal costs of compliance are increasing in absolute and relative terms, so we see increasing consolidation pressure in UK personal lines and in German and Italian mid-market non-life,” Roope added.

Balance sheet flexibility

One example of the importance of scale is LV=, which was acquired by Allianz in 2020.

Remaining independent can only occur when there is sufficient balance sheet flexibility and diversification. At the time of acquisition, LV= lacked the scale to keep absorbing regulatory and capital costs as an independent, so the most viable option was to sell to a global insurer.

Mario Conde, partner in Bain and Company’s Financial Services practice said: “Bain’s 2026 global M&A Report shows that financial services is experiencing a pattern visible across capital-heavy industries – scale consolidation driven by the need to amortise regulatory and technology investment across larger volumes.”

He added that the report showed “a close analogue to insurance in terms of capital intensity and regulatory overhead – M&A deals that combined both increased scale and widened capabilities, generated roughly 30% better gains in valuation than deals that pursued either just the scope or scale dimension alone”.

Bain’s team believe this same dynamic is visible in UK personal lines.

“For mid-tier insurers still weighing their options, the window for acting from a position of strength, rather than reacting to deteriorating capital adequacy or regulatory pressure, is narrowing faster than many boards may appreciate,” Conde warned.

Abbe agreed, adding: “We certainly see M&A being a key topic across the board. The largest companies want to create fast growth, but the medium-sized companies are also looking to be an acquirer.

”The smaller companies want actuarial talent, data, technology and geographic spread, and so they want to either be acquired or to be affiliated with the mid-sized to larger companies to improve their capabilities.”

Sufficient realism?

As for whether the boards of mid-tier insurers are being sufficiently realistic about their strategic options – growth, partnership, consolidation or orderly exit, as opposed deferring difficult decisions – Roope said that many are not.

“The most common pattern we observe is incremental optimism – successive three-year plans that assume combined ratio improvement, expense ratio reduction and modest growth simultaneously, year after year, without any of them materialising,” he noted.

Roope said that his firm has found that boards tend to defer the harder conversations – such as those concerning partnership, sale, portfolio transfer and orderly run-off – because each of those outcomes implicates hard decisions.

“Boards that act in year one of underperformance preserve optionality, whereas those that wait until year three are negotiating from weakness,” he suggested.

Abbe added that the challenge for boards is that future market cycles are going to happen faster than they did in the past. He therefore advised boards to help their companies to succeed by moving more quickly.

An example of this is the recent shifting of board conversations from profitability to growth. The trouble is that if everyone looks to grow simultaneously, the speed of the market cycle becomes accelerated.

He concluded: “A realistic board understands that they need to help their management teams to move quickly. If they don’t back nimble decision-making, then they are unlikely to be realistic with their expectations of future performance.”